| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1012488570 |
| P356 | DOI | 10.1038/SJ.ONC.1203628 |
| P698 | PubMed publication ID | 10871851 |
| P5875 | ResearchGate publication ID | 12446707 |
| P2093 | author name string | Schmidt L | |
| Zbar B | |||
| Nakaigawa N | |||
| Weirich G | |||
| P2860 | cites work | Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product | Q24310794 |
| Paxillin: a new vinculin-binding protein present in focal adhesions | Q24678834 | ||
| A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family | Q28285975 | ||
| c-Src enhances the spreading of src-/- fibroblasts on fibronectin by a kinase-independent mechanism | Q30193362 | ||
| Identification and characterization of a novel cytoskeleton-associated pp60src substrate | Q30195583 | ||
| Association of p60src with Triton X-100-resistant cellular structure correlates with morphological transformation | Q30450902 | ||
| Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype | Q35787720 | ||
| The protein-tyrosine kinase substrate, p81, is homologous to a chicken microvillar core protein | Q36214322 | ||
| Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells | Q36236279 | ||
| Activating mutations for the Met tyrosine kinase receptor in human cancer | Q36595980 | ||
| Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth | Q36734562 | ||
| Chromosome imbalances in papillary renal cell carcinoma and first cytogenetic data of familial cases analyzed by comparative genomic hybridization | Q36842062 | ||
| Talin is phosphorylated on tyrosine in chicken embryo fibroblasts transformed by Rous sarcoma virus | Q37392123 | ||
| Molecular cytogenetics of renal cell tumors | Q40715328 | ||
| Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product | Q40794270 | ||
| Hereditary papillary renal cell carcinoma | Q40814773 | ||
| c-Src kinase activity is required for hepatocyte growth factor-induced motility and anchorage-independent growth of mammary carcinoma cells | Q40990822 | ||
| Activation and translocation of c-Src to the cytoskeleton by both platelet-derived growth factor and epidermal growth factor | Q41370996 | ||
| MET(PRC) mutations in the Ron receptor result in upregulation of tyrosine kinase activity and acquisition of oncogenic potential | Q42809617 | ||
| Activating mutations in the Met receptor overcome the requirement for autophosphorylation of tyrosines crucial for wild type signaling | Q42810811 | ||
| Novel mutations of the MET proto-oncogene in papillary renal carcinomas. | Q42815807 | ||
| Signaling requirements for oncogenic forms of the Met tyrosine kinase receptor. | Q42824006 | ||
| Point mutations in the tyrosine kinase domain release the oncogenic and metastatic potential of the ron receptor | Q42826965 | ||
| Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas | Q45345804 | ||
| Vinculin: A cytoskeletal target of the transforming protein of rous sarcoma virus | Q45802101 | ||
| P433 | issue | 26 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2996-3002 | |
| P577 | publication date | 2000-06-01 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Tumorigenesis mediated by MET mutant M1268T is inhibited by dominant-negative Src. | |
| P478 | volume | 19 |
| Q42809894 | A direct role for Met endocytosis in tumorigenesis. |
| Q40373004 | Altered exon usage in the juxtamembrane domain of mouse and human RON regulates receptor activity and signaling specificity |
| Q47116036 | Cabozantinib inhibits tumor growth and metastasis of a patient-derived xenograft model of papillary renal cell carcinoma with MET mutation |
| Q34002709 | Cancer driver mutations in protein kinase genes |
| Q30374663 | Computational modeling of structurally conserved cancer mutations in the RET and MET kinases: the impact on protein structure, dynamics, and stability. |
| Q40075732 | Diacylglycerol kinase-alpha mediates hepatocyte growth factor-induced epithelial cell scatter by regulating Rac activation and membrane ruffling. |
| Q34584046 | Dysregulation of Met receptor tyrosine kinase activity in invasive tumors |
| Q39214964 | HGF–MET Cascade, a Key Target for Inhibiting Cancer Metastasis: The Impact of NK4 Discovery on Cancer Biology and Therapeutics |
| Q44737495 | Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy |
| Q30415408 | Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells |
| Q33969327 | Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway |
| Q38031834 | Oncogenic signaling by tyrosine kinases of the SRC family in advanced colorectal cancer |
| Q28212407 | Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition |
| Q33510934 | Sequence and structure signatures of cancer mutation hotspots in protein kinases |
| Q42828980 | Structural basis of oncogenic activation caused by point mutations in the kinase domain of the MET proto-oncogene: modeling studies |
| Q40343230 | Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases |
| Q39876378 | The D816V mutation of c-Kit circumvents a requirement for Src family kinases in c-Kit signal transduction |
| Q37765586 | Understanding the molecular genetics of renal cell neoplasia: implications for diagnosis, prognosis and therapy |
Search more.